Interaction among dietary n‐3 and n‐6 polyunsaturated fatty acid intake, fatty acid desaturase 2 genetic variants, and low‐density lipoprotein cholesterol levels in type 2 diabetes patients

Abstract Aims/Introduction Fatty acid desaturase (FADS) genetic polymorphisms are strongly correlated with the risk of dyslipidemia and cardiovascular disease. In this study, we examined the impact of FADS1 and FADS2 genetic variants on plasma lipid status, and assessed interactions between FADS gen...

Full description

Bibliographic Details
Main Authors: Pei‐Chi Huang, Hsuan Cheng, Yu‐Ting Su, Meng‐Chuan Huang, Chih‐Cheng Hsu, Shang‐Jyh Hwang, Shyi‐Jang Shin, Wen‐Tsan Chang
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Journal of Diabetes Investigation
Subjects:
Online Access:https://doi.org/10.1111/jdi.13944
_version_ 1797937945748963328
author Pei‐Chi Huang
Hsuan Cheng
Yu‐Ting Su
Meng‐Chuan Huang
Chih‐Cheng Hsu
Shang‐Jyh Hwang
Shyi‐Jang Shin
Wen‐Tsan Chang
author_facet Pei‐Chi Huang
Hsuan Cheng
Yu‐Ting Su
Meng‐Chuan Huang
Chih‐Cheng Hsu
Shang‐Jyh Hwang
Shyi‐Jang Shin
Wen‐Tsan Chang
author_sort Pei‐Chi Huang
collection DOAJ
description Abstract Aims/Introduction Fatty acid desaturase (FADS) genetic polymorphisms are strongly correlated with the risk of dyslipidemia and cardiovascular disease. In this study, we examined the impact of FADS1 and FADS2 genetic variants on plasma lipid status, and assessed interactions between FADS genetic polymorphisms and plasma n‐3/n‐6 fatty acids regarding lipid status within a population of 816 Taiwanese patients with type 2 diabetes. Materials and Methods Selected tag single‐nucleotide polymorphisms (FADS1 rs174546 [T/C]; FADS2 rs174602 [A/G] and rs2072114 [A/G]) were genotyped (n = 816). Results The distribution of genotypes were compared with reports publicly available in the Genome Aggregation Database for East Asian populations (https://gnomad.broadinstitute.org). In the subgroup of patients not taking lipid‐lowering medications (n = 192), we observed that the G allele of FADS2 rs174602 was statistically significantly correlated with lower low‐density lipoprotein cholesterol (LDL‐C) concentrations (P = 0.001), whereas the G allele of rs2072114 was marginally associated with LDL‐C concentrations (P = 0.091). Using a general linear model adjusted for confounding factors, statistically significant interactions (P = 0.016) between single‐nucleotide polymorphisms in rs2072114 and a low alpha‐linolenic acid (18:3n‐3)/linoleic acid (18:2n‐6) ratio; the G allele correlated with lower LDL‐C levels among individuals with a low alpha‐linolenic acid/linoleic acid ratio. Interaction between rs174602 single‐nucleotide polymorphisms and low alpha‐linolenic acid/linoleic acid values on LDL‐C was only marginally significant (P = 0.063). Conclusions Our results show the role of n‐3/n‐6 dietary polyunsaturated fatty acids in modifying the effects of genetic susceptibility on lipoprotein concentrations in patients with type 2 diabetes. Our findings highlight the potential of interventions with dietary polyunsaturated fatty acids regarding developing individualized prevention strategies for type 2 diabetes presenting with co‐occurring dyslipidemia and cardiovascular diseases.
first_indexed 2024-04-10T18:53:16Z
format Article
id doaj.art-1c5aa1cd80ab45a9a8ded8be325824d7
institution Directory Open Access Journal
issn 2040-1116
2040-1124
language English
last_indexed 2024-04-10T18:53:16Z
publishDate 2023-02-01
publisher Wiley
record_format Article
series Journal of Diabetes Investigation
spelling doaj.art-1c5aa1cd80ab45a9a8ded8be325824d72023-02-01T05:12:51ZengWileyJournal of Diabetes Investigation2040-11162040-11242023-02-0114229730810.1111/jdi.13944Interaction among dietary n‐3 and n‐6 polyunsaturated fatty acid intake, fatty acid desaturase 2 genetic variants, and low‐density lipoprotein cholesterol levels in type 2 diabetes patientsPei‐Chi Huang0Hsuan Cheng1Yu‐Ting Su2Meng‐Chuan Huang3Chih‐Cheng Hsu4Shang‐Jyh Hwang5Shyi‐Jang Shin6Wen‐Tsan Chang7Department of Public Health and Environmental Medicine, School of Medicine, College of Medicine Kaohsiung Medical University Kaohsiung TaiwanDepartment of Public Health and Environmental Medicine, School of Medicine, College of Medicine Kaohsiung Medical University Kaohsiung TaiwanDepartment of Public Health and Environmental Medicine, School of Medicine, College of Medicine Kaohsiung Medical University Kaohsiung TaiwanDepartment of Public Health and Environmental Medicine, School of Medicine, College of Medicine Kaohsiung Medical University Kaohsiung TaiwanInstitute of Population Health Sciences National Health Research Institutes Zhunan TaiwanDepartment of Internal Medicine Kaohsiung Medical University Hospital, Kaohsiung Medical University Kaohsiung TaiwanDepartment of Internal Medicine Kaohsiung Medical University Hospital, Kaohsiung Medical University Kaohsiung TaiwanDivision of General and Digestive Surgery, Department of Surgery Kaohsiung Medical University Hospital Kaohsiung TaiwanAbstract Aims/Introduction Fatty acid desaturase (FADS) genetic polymorphisms are strongly correlated with the risk of dyslipidemia and cardiovascular disease. In this study, we examined the impact of FADS1 and FADS2 genetic variants on plasma lipid status, and assessed interactions between FADS genetic polymorphisms and plasma n‐3/n‐6 fatty acids regarding lipid status within a population of 816 Taiwanese patients with type 2 diabetes. Materials and Methods Selected tag single‐nucleotide polymorphisms (FADS1 rs174546 [T/C]; FADS2 rs174602 [A/G] and rs2072114 [A/G]) were genotyped (n = 816). Results The distribution of genotypes were compared with reports publicly available in the Genome Aggregation Database for East Asian populations (https://gnomad.broadinstitute.org). In the subgroup of patients not taking lipid‐lowering medications (n = 192), we observed that the G allele of FADS2 rs174602 was statistically significantly correlated with lower low‐density lipoprotein cholesterol (LDL‐C) concentrations (P = 0.001), whereas the G allele of rs2072114 was marginally associated with LDL‐C concentrations (P = 0.091). Using a general linear model adjusted for confounding factors, statistically significant interactions (P = 0.016) between single‐nucleotide polymorphisms in rs2072114 and a low alpha‐linolenic acid (18:3n‐3)/linoleic acid (18:2n‐6) ratio; the G allele correlated with lower LDL‐C levels among individuals with a low alpha‐linolenic acid/linoleic acid ratio. Interaction between rs174602 single‐nucleotide polymorphisms and low alpha‐linolenic acid/linoleic acid values on LDL‐C was only marginally significant (P = 0.063). Conclusions Our results show the role of n‐3/n‐6 dietary polyunsaturated fatty acids in modifying the effects of genetic susceptibility on lipoprotein concentrations in patients with type 2 diabetes. Our findings highlight the potential of interventions with dietary polyunsaturated fatty acids regarding developing individualized prevention strategies for type 2 diabetes presenting with co‐occurring dyslipidemia and cardiovascular diseases.https://doi.org/10.1111/jdi.13944DiabetesFADS1FADS2
spellingShingle Pei‐Chi Huang
Hsuan Cheng
Yu‐Ting Su
Meng‐Chuan Huang
Chih‐Cheng Hsu
Shang‐Jyh Hwang
Shyi‐Jang Shin
Wen‐Tsan Chang
Interaction among dietary n‐3 and n‐6 polyunsaturated fatty acid intake, fatty acid desaturase 2 genetic variants, and low‐density lipoprotein cholesterol levels in type 2 diabetes patients
Journal of Diabetes Investigation
Diabetes
FADS1
FADS2
title Interaction among dietary n‐3 and n‐6 polyunsaturated fatty acid intake, fatty acid desaturase 2 genetic variants, and low‐density lipoprotein cholesterol levels in type 2 diabetes patients
title_full Interaction among dietary n‐3 and n‐6 polyunsaturated fatty acid intake, fatty acid desaturase 2 genetic variants, and low‐density lipoprotein cholesterol levels in type 2 diabetes patients
title_fullStr Interaction among dietary n‐3 and n‐6 polyunsaturated fatty acid intake, fatty acid desaturase 2 genetic variants, and low‐density lipoprotein cholesterol levels in type 2 diabetes patients
title_full_unstemmed Interaction among dietary n‐3 and n‐6 polyunsaturated fatty acid intake, fatty acid desaturase 2 genetic variants, and low‐density lipoprotein cholesterol levels in type 2 diabetes patients
title_short Interaction among dietary n‐3 and n‐6 polyunsaturated fatty acid intake, fatty acid desaturase 2 genetic variants, and low‐density lipoprotein cholesterol levels in type 2 diabetes patients
title_sort interaction among dietary n 3 and n 6 polyunsaturated fatty acid intake fatty acid desaturase 2 genetic variants and low density lipoprotein cholesterol levels in type 2 diabetes patients
topic Diabetes
FADS1
FADS2
url https://doi.org/10.1111/jdi.13944
work_keys_str_mv AT peichihuang interactionamongdietaryn3andn6polyunsaturatedfattyacidintakefattyaciddesaturase2geneticvariantsandlowdensitylipoproteincholesterollevelsintype2diabetespatients
AT hsuancheng interactionamongdietaryn3andn6polyunsaturatedfattyacidintakefattyaciddesaturase2geneticvariantsandlowdensitylipoproteincholesterollevelsintype2diabetespatients
AT yutingsu interactionamongdietaryn3andn6polyunsaturatedfattyacidintakefattyaciddesaturase2geneticvariantsandlowdensitylipoproteincholesterollevelsintype2diabetespatients
AT mengchuanhuang interactionamongdietaryn3andn6polyunsaturatedfattyacidintakefattyaciddesaturase2geneticvariantsandlowdensitylipoproteincholesterollevelsintype2diabetespatients
AT chihchenghsu interactionamongdietaryn3andn6polyunsaturatedfattyacidintakefattyaciddesaturase2geneticvariantsandlowdensitylipoproteincholesterollevelsintype2diabetespatients
AT shangjyhhwang interactionamongdietaryn3andn6polyunsaturatedfattyacidintakefattyaciddesaturase2geneticvariantsandlowdensitylipoproteincholesterollevelsintype2diabetespatients
AT shyijangshin interactionamongdietaryn3andn6polyunsaturatedfattyacidintakefattyaciddesaturase2geneticvariantsandlowdensitylipoproteincholesterollevelsintype2diabetespatients
AT wentsanchang interactionamongdietaryn3andn6polyunsaturatedfattyacidintakefattyaciddesaturase2geneticvariantsandlowdensitylipoproteincholesterollevelsintype2diabetespatients